Inhibitory effect on MRSA and VRE Bottromycin A2
Date:July 03 2020Web Page No:520044
Bottromycin A2 is a natural product of bottromycins isolated by Dr. Hamao Umezawa in Institute of Microbial Chemistry (Bikaken) and purified from Streptomyces.1)
* Please do not hesitate to contact Funakoshi if you need a SDF (Structure Data Format) file and/or bulk purchase (large quantity) of the compounds.
* This product is for research use only.
Chemical structure of Bottromycin A2 (#00592)
What is Bottromycin A2
Bottromycin A2 has a cyclic peptide structure and shows inhibitory activity against gram-positive bacteria. It is also reported to have low toxicity but strong antibacterial activity against drug-resistant bacteria, such as against MRSA(Methicillin-Resistant Staphylococcus Aureus) and VRE(Vancomycin-Resistant enterococci) 2,3). The mechanism of Bottromycin A2 is known to inhibit bacterial protein synthesis by binding to the A-site of ribosome and blocking aminoacyl-tRNA binding 4,5). Its biosynthesis, total synthesis, derivative synthesis and their biological activities have also been studied, and several papers have been reported 3,6).
Specification
| CAS# | 15005-62-6 |
|---|---|
| Molecular Formula | C42H62N8O7S |
| Molecular Weight | 823.067 |
| Source | Streptomyces, No. 3668-L2 |
| Purity | >80% (HPLC) |
| Solubility | Soluble in MeOH, Ether and H2O Insoluble in n-Hexane |
Application Note
- Bottromycin A2 showed inhibitory activity against Xanthomonas oryzae pv., which causes white leaf blight in Oryza sativa oryzae, was active in vitro at an MIC of 2μg/ml 7).
Bottromycin A2 shows potent antibacterial activities against methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococci (VRE) among other Gram-positive bacteria and mycoplasma.2,3) The mechanism of action of botromycin A2 is known to inhibit bacterial protein synthesis by binding to the A-site of the ribosome and blocking aminoacyl-tRNA binding.4,5)
- Nakamura, S. et al., J. Antibiot., 18(1), 47-52(1965). [PMID:14282373]
- Nakamura, S. et al., J. Antibiot., 20(1), 1-5(1967). [PMID:6072278]
- Kobayashi, Y. et al., Bioorg. Med. Chem. Lett., 20(20), 6116-6120(2010). [PMID:20833545]
- Otaka, T. and Kaji, A., J. Biol. Chem., 251(8), 2299-2306(1976). [PMID:770464]
- Lin, Y.-C. et al., J. Antibiot., 21(8), 471-476(1968). [PMID:4884807]
- Yamada, T. et al., J. Org. Chem., 83(13), 7135-7149(2018). [PMID:29560726]
- Park, S.B. et al., J. Microbiol. Biotechnol., 21(12), 1236-1242(2011). [PMID:22210608]
- Product Code: 00592
- Supplier: IMC
- Size: 1mg
- Price: $500
- ※Prices on our website are for your reference only. Please inquire your distributor for your prices.
- ※Please note that Product Information or Price may change without notice.
Biological activity of Bottromycin A2 3)
The value inside the parentheses is MIC (minimum inhibitory concentration).
| Bacterial name | MIC (μg/ml) |
|---|---|
| S. aureus FDA209P | 1 |
| S. aureus Smith | 1 |
| MRSA HH-1 | 1 |
| MRSA 92-1191 | 2 |
| VRE NCTC12201 | 1 |
| VRE NCTC12203 | 0.5 |
* Biological activity of the product was not verified. The values shown above were cited from the references.
Reference

[Date : May 19 2026 00:10]
| Detail | Product Name | Product Code | Supplier | Size | Price | ||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Bottromycin A2, Antibacterial (Gram-Positive) DatasheetThis may not be the latest data sheet. |
00592 | IMCInstitute of Microbial Chemistry | 1 mg | $500 | |||||||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||||||||||||
[Date : May 19 2026 00:10]
Bottromycin A2, Antibacterial (Gram-Positive)
DatasheetThis may not be the latest data sheet.
| Description |
M.W.: 823.06 Purity : > 80% (HPLC) Molecular Formula : C42H62N8O7S Solubility : Soluble in H2O, Methanol, and Ether, Insoluble in n-Hexane. Bottromycin A2 has a cyclic peptide structure and shows inhibitory activity against gram-positive bacteria. It is also reported to have low toxicity but strong antibacterial activity against drug-resistant bacteria, such as against MRSA(Methicillin-Resistant Staphylococcus Aureus) and VRE(Vancomycin-Resistant enterococci). The mechanism of Bottromycin A2 is known to inhibit bacterial protein synthesis by binding to the A-site of ribosome and blocking aminoacyl-tRNA binding. |
||
|---|---|---|---|
| Storage | -20°C | CAS | 15005-62-6 |
| Link |
Bioactive Compounds |
||
CONTACT
export@funakoshi.co.jp
